Naomi: a new modelling tool for estimating HIV epidemic indicators at the district level in sub-Saharan Africa.


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
09 2021
Historique:
received: 28 04 2021
accepted: 19 07 2021
entrez: 21 9 2021
pubmed: 22 9 2021
medline: 30 10 2021
Statut: ppublish

Résumé

HIV planning requires granular estimates for the number of people living with HIV (PLHIV), antiretroviral treatment (ART) coverage and unmet need, and new HIV infections by district, or equivalent subnational administrative level. We developed a Bayesian small-area estimation model, called Naomi, to estimate these quantities stratified by subnational administrative units, sex, and five-year age groups. Small-area regressions for HIV prevalence, ART coverage and HIV incidence were jointly calibrated using subnational household survey data on all three indicators, routine antenatal service delivery data on HIV prevalence and ART coverage among pregnant women, and service delivery data on the number of PLHIV receiving ART. Incidence was modelled by district-level HIV prevalence and ART coverage. Model outputs of counts and rates for each indicator were aggregated to multiple geographic and demographic stratifications of interest. The model was estimated in an empirical Bayes framework, furnishing probabilistic uncertainty ranges for all output indicators. Example results were presented using data from Malawi during 2016-2018. Adult HIV prevalence in September 2018 ranged from 3.2% to 17.1% across Malawi's districts and was higher in southern districts and in metropolitan areas. ART coverage was more homogenous, ranging from 75% to 82%. The largest number of PLHIV was among ages 35 to 39 for both women and men, while the most untreated PLHIV were among ages 25 to 29 for women and 30 to 34 for men. Relative uncertainty was larger for the untreated PLHIV than the number on ART or total PLHIV. Among clients receiving ART at facilities in Lilongwe city, an estimated 71% (95% CI, 61% to 79%) resided in Lilongwe city, 20% (14% to 27%) in Lilongwe district outside the metropolis, and 9% (6% to 12%) in neighbouring Dowa district. Thirty-eight percent (26% to 50%) of Lilongwe rural residents and 39% (27% to 50%) of Dowa residents received treatment at facilities in Lilongwe city. The Naomi model synthesizes multiple subnational data sources to furnish estimates of key indicators for HIV programme planning, resource allocation, and target setting. Further model development to meet evolving HIV policy priorities and programme need should be accompanied by continued strengthening and understanding of routine health system data.

Identifiants

pubmed: 34546657
doi: 10.1002/jia2.25788
pmc: PMC8454682
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25788

Subventions

Organisme : NIAID NIH HHS
ID : R37 AI029168
Pays : United States
Organisme : NIAID NIH HHS
ID : R03 AI125001
Pays : United States
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI029168
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI136664
Pays : United States

Informations de copyright

© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

AIDS. 2017 Apr;31 Suppl 1:S87-S94
pubmed: 28296804
PLoS Med. 2020 Mar 6;17(3):e1003042
pubmed: 32142509
AIDS. 2001 Apr;15 Suppl 3:S41-8
pubmed: 11421182
AIDS. 2019 Dec 15;33 Suppl 3:S213-S226
pubmed: 31490781
Bull World Health Organ. 2006 Apr;84(4):320-6
pubmed: 16628306
Lancet HIV. 2021 Jun;8(6):e363-e375
pubmed: 34087097
PLoS One. 2019 May 3;14(5):e0216388
pubmed: 31050678
AIDS. 2018 May 15;32(8):957-963
pubmed: 29547437
Stat Methods Med Res. 2021 May;30(5):1187-1210
pubmed: 33525965
AIDS. 2018 Mar 27;32(6):819-824
pubmed: 29369167
Bull World Health Organ. 2016 Oct 1;94(10):772-776
pubmed: 27843168
Popul Health Metr. 2015 Sep 02;13:22
pubmed: 26336361
Nature. 2019 Jun;570(7760):189-193
pubmed: 31092927
PLoS One. 2019 Feb 22;14(2):e0212445
pubmed: 30794619
AIDS. 2019 Dec 15;33 Suppl 3:S227-S234
pubmed: 31805028
Sci Rep. 2017 Aug 22;7(1):9093
pubmed: 28831171
J Int AIDS Soc. 2016 Feb 10;19(1):20171
pubmed: 26869359
Int J Health Geogr. 2018 Jul 11;17(1):27
pubmed: 29996876
AIDS. 2014 Nov;28 Suppl 4:S469-76
pubmed: 25406750
AIDS. 2019 Dec 15;33 Suppl 3:S203-S211
pubmed: 31343430
BMC Public Health. 2020 Mar 23;20(1):379
pubmed: 32293367
Epidemiology. 2012 Sep;23(5):721-8
pubmed: 22627902
Sci Transl Med. 2017 Mar 29;9(383):
pubmed: 28356504
AIDS. 2016 Jun 1;30(9):1467-74
pubmed: 26919737
BMC Public Health. 2020 Sep 9;20(1):1375
pubmed: 32907565
AIDS. 2019 Dec 15;33 Suppl 3:S235-S244
pubmed: 31800403
J Int AIDS Soc. 2020 Nov;23(11):e25631
pubmed: 33225559
AIDS. 2019 Dec 15;33 Suppl 3:S255-S269
pubmed: 31764066

Auteurs

Jeffrey W Eaton (JW)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.

Laura Dwyer-Lindgren (L)

Instituted for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.
Department of Health Metrics Sciences, University of Washington, Seattle, Washington, USA.

Steve Gutreuter (S)

Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Megan O'Driscoll (M)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Department of Genetics, University of Cambridge, Cambridge, UK.

Oliver Stevens (O)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.

Sumali Bajaj (S)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Department of Zoology, University of Oxford, Oxford, UK.

Rob Ashton (R)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.

Alexandra Hill (A)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.

Emma Russell (E)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.

Rachel Esra (R)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.

Nicolas Dolan (N)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.

Yusuf O Anifowoshe (YO)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.

Mark Woodbridge (M)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.

Ian Fellows (I)

Fellows Statistics, San Diego, California, USA.

Robert Glaubius (R)

Avenir Health, Glastonbury, Connecticut, USA.

Emily Haeuser (E)

Instituted for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.

Taylor Okonek (T)

Department of Biostatistics, University of Washington, Seattle, Washington, USA.

John Stover (J)

Avenir Health, Glastonbury, Connecticut, USA.

Matthew L Thomas (ML)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Joint Centre for Excellence in Environmental Intelligence, University of Exeter and the Met Office, Exeter, UK.

Jon Wakefield (J)

Department of Biostatistics, University of Washington, Seattle, Washington, USA.
Department of Statistics, University of Washington, Seattle, Washington, USA.

Timothy M Wolock (TM)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Department of Mathematics, Imperial College London, London, UK.

Jonathan Berry (J)

Fjelltopp, Padiham, UK.

Tomasz Sabala (T)

Fjelltopp, Padiham, UK.

Nathan Heard (N)

US Department of State, Washington, District of Columbia, USA.

Stephen Delgado (S)

ICAP, Mailman School of Public Health, Columbia University, New York, New York, USA.

Andreas Jahn (A)

Department of HIV & AIDS, Ministry of Health, Lilongwe, Malawi.
International Training and Education Center for Health, Department of Global Health, University of Washington, Seattle, Washington, USA.

Thokozani Kalua (T)

Department of HIV & AIDS, Ministry of Health, Lilongwe, Malawi.

Tiwonge Chimpandule (T)

Department of HIV & AIDS, Ministry of Health, Lilongwe, Malawi.
International Training and Education Center for Health, Department of Global Health, University of Washington, Seattle, Washington, USA.

Andrew Auld (A)

Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Lilongwe, Malawi.

Evelyn Kim (E)

Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Lilongwe, Malawi.

Danielle Payne (D)

Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Lilongwe, Malawi.

Leigh F Johnson (LF)

Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.

Richard G FitzJohn (RG)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.

Ian Wanyeki (I)

Strategic Information Department, Joint United Nations Program on HIV/AIDS (UNAIDS), Geneva, Switzerland.

Mary I Mahy (MI)

Strategic Information Department, Joint United Nations Program on HIV/AIDS (UNAIDS), Geneva, Switzerland.

Ray W Shiraishi (RW)

Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH